Radiopharm Theranostics Ltd (RADX) Total Current Liabilities (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Total Current Liabilities of $95635.8 for Q2 2025, down 17.43% year-over-year from $115828.6 in Q2 2024, and down 17.43% quarter-over-quarter from $115828.6 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Total Current Liabilities (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Total Current Liabilities for 2 consecutive years, with $95635.8 the latest figure, recorded in Q2 2025.
- In Q2 2025, Total Current Liabilities fell 17.43% year-over-year to $95635.8; the TTM figure through Jun 2025 stood at $95635.8 (down 17.43% YoY), while the FY2025 annual figure was $14.9 million, down 15.04% from the prior year.
- Total Current Liabilities declined to $95635.8 in Q2 2025 per RADX's latest filing, from $115828.6 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $115828.6 in Q2 2024 and bottomed at $95635.8 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 95,635.79 |
| Jun 30, 2024 | 115,828.63 |